|
Volumn 96, Issue 1, 2002, Pages 49-52
|
Diagnostic utility of the HepPar1 antibody to differentiate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration samples
|
Author keywords
Fine needle aspiration (FNA); Hepatocellular carcinoma (HCC); HepPar1; Liver tumor; Metastatic carcinoma (MC)
|
Indexed keywords
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY HEPPAR1;
PARAFFIN;
TUMOR MARKER;
UNCLASSIFIED DRUG;
ANTIBODY DETECTION;
ARTICLE;
ASPIRATION BIOPSY;
BILE DUCT CARCINOMA;
CELL DIFFERENTIATION;
CORRELATION ANALYSIS;
CYTOPATHOLOGY;
DIAGNOSTIC VALUE;
DIFFERENTIAL DIAGNOSIS;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
LIVER CELL;
LIVER CELL CARCINOMA;
LIVER METASTASIS;
MAJOR CLINICAL STUDY;
MALLORY BODY;
METASTASIS POTENTIAL;
PRIORITY JOURNAL;
SAMPLING;
STAINING;
ANTIBODIES, MONOCLONAL;
BIOPSY, NEEDLE;
BREAST NEOPLASMS;
CARCINOMA, HEPATOCELLULAR;
CELL DIFFERENTIATION;
CHOLANGIOCARCINOMA;
COLONIC NEOPLASMS;
DIAGNOSIS, DIFFERENTIAL;
HEPATOCYTES;
HUMANS;
IMMUNOHISTOCHEMISTRY;
LIVER NEOPLASMS;
PANCREATIC NEOPLASMS;
SENSITIVITY AND SPECIFICITY;
STOMACH NEOPLASMS;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 0037170128
PISSN: 0008543X
EISSN: None
Source Type: Journal
DOI: 10.1002/cncr.10311 Document Type: Article |
Times cited : (71)
|
References (10)
|